Dominik Andreas Barth
14PUBLICATIONS
15CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (14)
Sort by Publication Date:
|Nov 25, 2022
Improved overall survival of metastatic renal cell carcinoma patients in the era of modern tyrosine kinase inhibitors and immune checkpoint inhibitors: results from a real-life, population-based Austrian study comprising three decades of follow-up.Hannah Fluhrer, Georg C Hutterer, Sylvia Golbeck
|Mar 17, 2022
Evaluation of autoantibodies as predictors of treatment response and immune-related adverse events during the treatment with immune checkpoint inhibitors: A prospective longitudinal pan-cancer study.Dominik A Barth, Stefanie Stanzer, Jasmin Spiegelberg
|Aug 27, 2021
MiR-200c-3p Modulates Cisplatin Resistance in Biliary Tract Cancer by ZEB1-Independent Mechanisms.Florian Posch, Felix Prinz, Amar Balihodzic
|Mar 03, 2021
Involvement of Long Non-Coding RNAs in Glucose Metabolism in Cancer.Amar Balihodzic, Dominik A Barth, Felix Prinz
|Sep 30, 2020
Involvement of Long Non-Coding RNAs (lncRNAs) in Tumor Angiogenesis.Julia Teppan, Dominik A Barth, Felix Prinz
|Aug 23, 2020
C-Reactive Protein (CRP) Levels in Immune Checkpoint Inhibitor Response and Progression in Advanced Non-Small Cell Lung Cancer: A Bi-Center Study.Jakob M Riedl, Dominik A Barth, Wolfgang M Brueckl
Pageof 3
Frequent Collaborators
10 joint publications
Martin Pichler
4 joint publications
Christiane Klec
3 joint publications
Jakob Michael Riedl
3 joint publications
Katharina Jonas
2 joint publications
Peter Kornprat
2 joint publications
Armin Gerger
2 joint publications
Amar Balihodzic
1 joint publications
Thomas Bauernhofer
1 joint publications
Jörg Lindenmann
1 joint publications
Wolfgang M Brueckl
